info icon

This is a non-core endpoint: only basic statistics are computed.

Compression of brain

G6_COMPBRAIN

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G93.5
  • Hospital discharge: ICD-9 3484
  • Cause of death: ICD-10 G93.5
  • Cause of death: ICD-9 3484

2 out of 7 registries used, show all original rules.

36

4. Check minimum number of events

None

36

5. Include endpoints

None

36

6. Filter based on genotype QC (FinnGen only)

36

Control definitions (FinnGen only)

Control exclude
G6_OTHNEU

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G93
Name in latin
Compressio encephali

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 499 217 273
Only index persons 277 125 152
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.00 0.01
Median age at first event (years)
Whole population 55.50 56.32 54.58
Only index persons 55.00 56.56 53.71

-FinnGen-

Key figures

All Female Male
Number of individuals 36 16 20
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 50.86 45.98 54.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
0
+∞
8.66
2.1
0.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
0
+∞
6.42
1.8
0.0
mmol/l
1.8
—
—
6
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
9
16
7.10
3.95
2.8
1.8
ng/l
93.7
297.6
—
9
16
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
12
6.93
3.19
34.1
10.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
14
55
3.53
3.06
6.6
5.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
21
115
2.98
2.56
4.5
3.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
7
17
4.84
2.50
37.7
3.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
17
250
0.39
1.94
35.3
13.3
%
41.8
41.3
—
10
203
(3024561) Albumin [Mass/volume] in Serum or Plasma
18
102
2.53
1.91
6.9
3.8
g/l
31.8
36.5
2.08
18
97
(3026008) Bacteria identified in Urine by Culture
13
66
2.52
1.70
7.5
2.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
9
38
2.81
1.60
1.7
1.5
nmol/l
1066.7
1052.1
—
9
30
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
18
247
0.46
1.42
19.2
11.1
ml/min/173m2
86.0
85.0
0.04
18
206
(21494755) Public health laboratory ask at order entry panel
0
34
0.00
1.23
0.0
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
0
33
0.00
1.23
0.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
8
40
2.28
1.21
4.4
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
21
147
2.03
1.19
17.6
5.0
mmol/l
7.6
6.6
0.80
21
129
(3010813) Leukocytes [#/volume] in Blood
25
300
0.45
1.19
36.6
18.3
e9/l
8.1
6.7
1.89
25
293
(3026361) Erythrocytes [#/volume] in Blood
25
300
0.45
1.19
36.6
18.1
e12/l
4.3
4.6
2.22
25
293
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
20
138
2.01
1.18
4.3
5.9
umol/l
10.8
11.7
0.21
20
132
(3007461) Platelets [#/volume] in Blood
25
299
0.46
1.14
36.6
18.1
e9/l
266.1
246.5
0.70
25
293
(3003338) MCHC [Mass/volume]
19
246
0.52
1.06
34.9
15.2
g/l
332.6
333.0
0.07
19
246
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
28
0.00
1.03
0.0
2.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
31
0.00
1.02
0.0
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
32
0.00
1.00
0.0
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
37
2.10
1.00
3.0
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
13
81
1.95
0.98
2.8
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
11
66
1.96
0.91
1.5
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
27
0.00
0.81
0.0
2.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
10
61
1.89
0.78
5.0
3.3
%
97.0
93.8
—
10
61
(3020564) Creatinine [Moles/volume] in Serum or Plasma
24
281
0.56
0.74
27.6
14.0
umol/l
77.9
76.1
0.10
24
281
(3042936) Bacteria identified in Isolate by Culture
7
43
1.78
0.72
2.7
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
13
89
1.72
0.71
1.9
1.7
pmol/l
97.1
97.2
—
8
50
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
20
242
0.61
0.66
7.4
4.7
mmol/mol
44.1
38.8
0.80
20
232
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
25
286
0.59
0.62
11.5
9.3
u/l
36.8
25.8
0.80
25
280
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
22
0.00
0.61
0.0
3.7
—
5.9
—
0
22
(3002032) Base excess in Venous blood by calculation
0
22
0.00
0.61
0.0
3.7
—
3.0
—
0
17
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
60
1.66
0.61
2.8
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
11
78
1.59
0.50
2.1
2.1
u/l
71.0
58.8
0.27
11
70
(3037467) Urinalysis macro (dipstick) panel - Urine
21
175
1.48
0.46
8.1
4.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5
32
1.65
0.44
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
9
67
1.46
0.43
5.8
7.6
—
—
—
0
0
(3013512) EKG study
9
68
1.43
0.42
6.9
3.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
0
15
0.00
0.42
0.0
3.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
16
0.00
0.42
0.0
5.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
16
0.00
0.42
0.0
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
0
17
0.00
0.42
0.0
2.8
—
4.0
—
0
17
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
9
70
1.38
0.41
5.4
3.5
ng/l
1163.8
1648.9
—
9
58
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
18
0.00
0.41
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
18
0.00
0.41
0.0
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
18
0.00
0.41
0.0
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
8
105
0.69
0.35
3.0
2.2
ug/l
96.0
90.6
—
8
99
(3021589) Normoblasts [#/volume] in Blood
8
105
0.69
0.35
11.0
10.1
e9/l
0.0
0.0
—
8
81
(40761511) CBC panel - Blood by Automated count
25
276
0.69
0.35
27.5
11.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
9
75
1.27
0.28
3.9
3.4
mmol/l
2.4
2.4
—
9
68
(3023103) Potassium [Moles/volume] in Serum or Plasma
24
262
0.75
0.25
37.3
13.9
mmol/l
4.0
4.0
0.22
24
256
(3019550) Sodium [Moles/volume] in Serum or Plasma
24
262
0.75
0.25
38.7
13.6
mmol/l
140.1
139.8
0.29
24
255
(40768804) Tissue Pathology biopsy report
8
100
0.74
0.25
2.9
2.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
11
0.00
0.22
0.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
11
0.00
0.22
0.0
3.5
—
56.4
—
0
11
(1761482) Bacteria [#/volume] in Urine by Culture
0
10
0.00
0.22
0.0
7.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
6.4
—
16.3
—
0
10
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.9
—
268.9
—
0
10
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
0
10
0.00
0.22
0.0
4.9
—
24.6
—
0
10
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
2.7
—
25.3
—
0
12
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
12
0.00
0.21
0.0
1.8
—
0.8
—
0
12
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(1002224) Polysomnography panel
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
13
0.00
0.21
0.0
1.8
—
1.1
—
0
13
(3013650) Neutrophils [#/volume] in Blood by Automated count
14
161
0.79
0.21
7.4
11.1
e9/l
4.6
4.3
0.15
14
139
(3025941) Bacteria identified in Stool by Culture
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
17
190
0.80
0.19
5.2
3.3
mm/h
14.9
10.2
0.69
17
177
(3041096) Erythrocytes [Presence] in Urine by Automated
8
69
1.20
0.18
2.8
3.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
10
83
1.28
0.18
5.2
5.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
11
128
0.80
0.17
5.4
4.9
%
62.2
58.7
0.40
11
119
(3013115) Eosinophils [#/volume] in Blood
12
137
0.81
0.15
6.3
5.8
e9/l
0.2
0.2
0.16
12
121
(3019198) Lymphocytes [#/volume] in Blood
12
136
0.82
0.14
5.2
5.5
e9/l
1.7
1.7
0.04
12
118
(3006504) Eosinophils/100 leukocytes in Blood
11
124
0.84
0.11
5.4
5.0
%
2.4
3.0
0.31
11
116
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
18
194
0.86
0.10
3.1
3.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
12
133
0.85
0.09
5.2
5.5
e9/l
0.0
0.0
0.19
12
114
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
5
63
0.76
0.09
1.6
1.6
mmol/l
1.0
1.5
—
5
58
(3018418) pH of Serum or Plasma
7
65
1.10
0.09
4.0
3.8
—
7.4
—
0
8
(3022096) Basophils/100 leukocytes in Blood
11
122
0.86
0.08
5.1
4.9
%
0.5
0.6
0.14
11
112
(3015736) pH of Urine
9
100
0.87
0.07
2.8
3.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
98
0.89
0.07
3.4
3.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
12
131
0.87
0.07
5.2
5.6
e9/l
0.6
0.6
0.06
12
112
(3002030) Lymphocytes/100 leukocytes in Blood
12
128
0.91
0.03
5.2
5.1
%
20.9
26.5
1.37
12
120
(3044889) 12 lead EKG panel
16
165
0.95
0.00
3.9
3.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
12
124
0.95
0.00
5.4
5.4
%
8.0
8.7
0.41
12
116
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
8.6
—
0
5
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
2.2
—
4.0
—
0
5
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
2.2
—
108.2
—
0
5
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1.0
—
0
5
(4268621)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
60.2
—
0
6
(3034770) Mitochondria Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.7
—
7.0
—
0
6
(3014051) Protein [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4094501)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
7
68
1.04
0.00
2.7
2.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
0
9
0.00
0.00
0.0
7.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
5.8
—
8.8
—
0
6
(3013290) Carbon dioxide [Partial pressure] in Blood
0
6
0.00
0.00
0.0
1.2
—
4.7
—
0
6
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.7
—
1.4
—
0
6
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
6
0.00
0.00
0.0
1.2
—
9.4
—
0
6
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
4.1
—
0.0
—
0
9
(3008898) HLA-B27 [Presence]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
9
94
0.94
0.00
5.0
2.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint G6_COMPBRAIN and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_COMPBRAIN.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: G6_COMPBRAIN – Compression of brain

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data